1. Home
  2. VANI vs PCF Comparison

VANI vs PCF Comparison

Compare VANI & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivani Medical Inc. (DE)

VANI

Vivani Medical Inc. (DE)

SELL

Current Price

$1.16

Market Cap

111.0M

Sector

Health Care

ML Signal

SELL

Logo High Income Securities Fund

PCF

High Income Securities Fund

SELL

Current Price

$5.06

Market Cap

98.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
VANI
PCF
Founded
1998
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
111.0M
98.6M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
VANI
PCF
Price
$1.16
$5.06
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $3.83
N/A
AVG Volume (30 Days)
★ 153.0K
130.0K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $4,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.92
$4.95
52 Week High
$1.92
$6.31

Technical Indicators

Market Signals
Indicator
VANI
PCF
Relative Strength Index (RSI) 37.37 37.88
Support Level $1.15 $4.95
Resistance Level $1.25 $5.63
Average True Range (ATR) 0.04 0.08
MACD -0.00 0.00
Stochastic Oscillator 4.32 50.00

Price Performance

Historical Comparison
VANI
PCF

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.

About PCF High Income Securities Fund

High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.

Share on Social Networks: